Bullfrog AI (BFRG) shares soared on Monday as investors reacted to the company’s high-profile commercial agreement with one of the top-five pharmaceutical companies in the world. The unnamed partner has agreed to use its artificial intelligence (AI) platform for drug discovery, the micro-cap firm revealed in a press release today. More News from Barchart Following an explosive rally on March 30, BFRG stock is trading at a year-to-date high of $1.05. www.barchart.com Significance of the Pharma Deal fo ...